Posted 12 February, 2024
Metagenomi, Inc. IPO completed
IPO completed detected for ticker Nasdaq:MGX in a 424B4 filed on 12 February, 2024.
This is an initial public offering of shares of common stock of Metagenomi, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Metagenomi, Inc.
Health Care/Life Sciences • Biotechnology
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. Metagenomi forges these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific, and have a decreased risk of the immune response. Metagenomi's goal is to revolutionize gene editing for the benefit of patients around the world. The company was founded in 2018 and is headquartered in Emeryville, California.Market Cap
$442M
View Company Details
$442M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.